Hims & Hers Scales Technology-Enabled, Vertically Integrated Care — Neutral
HIMS Zacks Investment Research — November 11, 2025HIMS deepens its technology-enabled care model with new offerings in GLP-1 weight loss, hormone health, and custom treatments.
3 Internet Software Stocks to Buy From a Prospering Industry — Positive
NET PLTR RDDT Zacks Investment Research — November 11, 2025The Zacks Internet software industry participants like PLTR, NET and RDDT are benefiting from high demand for SaaS due to the increasing need for hybrid work, learning and diagnosis software, as well as cybersecurity applications.
Here's Why You Should Hold DexCom Stock in Your Portfolio for Now — Positive
DXCM Zacks Investment Research — November 11, 2025DXCM's strong Q3 growth, expanding CGM coverage and innovation-driven momentum position it for sustained adoption despite rising competition.
3 Reasons Why Growth Investors Shouldn't Overlook Badger Meter (BMI) — Positive
BMI Zacks Investment Research — November 11, 2025Badger Meter (BMI) is well positioned to outperform the market, as it exhibits above-average growth in financials.
3 Reasons Why Growth Investors Shouldn't Overlook Kontoor (KTB) — Positive
KTB Zacks Investment Research — November 11, 2025Kontoor (KTB) possesses solid growth attributes, which could help it handily outperform the market.
Is Fair Isaac (FICO) a Solid Growth Stock? 3 Reasons to Think "Yes" — Positive
FICO Zacks Investment Research — November 11, 2025Fair Isaac (FICO) is well positioned to outperform the market, as it exhibits above-average growth in financials.
3 Reasons Why Growth Investors Shouldn't Overlook American States Water (AWR) — Positive
AWR Zacks Investment Research — November 11, 2025American States Water (AWR) possesses solid growth attributes, which could help it handily outperform the market.
3 Reasons Why Growth Investors Shouldn't Overlook Life Time Group Holdings (LTH) — Positive
LTH Zacks Investment Research — November 11, 2025Life Time Group Holdings (LTH) possesses solid growth attributes, which could help it handily outperform the market.
3 Reasons Growth Investors Will Love Hecla Mining (HL) — Positive
HL Zacks Investment Research — November 11, 2025Hecla Mining (HL) could produce exceptional returns because of its solid growth attributes.
Is Orla Mining (ORLA) a Solid Growth Stock? 3 Reasons to Think "Yes" — Positive
ORLA Zacks Investment Research — November 11, 2025Orla Mining (ORLA) is well positioned to outperform the market, as it exhibits above-average growth in financials.
3 Reasons Why Growth Investors Shouldn't Overlook LeMaitre (LMAT) — Positive
LMAT Zacks Investment Research — November 11, 2025LeMaitre (LMAT) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Looking for a Growth Stock? 3 Reasons Why Neurocrine (NBIX) is a Solid Choice — Positive
NBIX Zacks Investment Research — November 11, 2025Neurocrine (NBIX) possesses solid growth attributes, which could help it handily outperform the market.
Ecolab Inc. (ECL) Presents at Baird 55th Annual Global Industrial Conference Transcript — Neutral
ECL Seeking Alpha — November 11, 2025Ecolab Inc. ( ECL ) Baird 55th Annual Global Industrial Conference November 11, 2025 11:15 AM EST Company Participants Christophe Beck - CEO & Chairman of the Board Conference Call Participants Andrew J. Wittmann - Robert W.
Johnson & Johnson (JNJ) Presents at UBS Global Healthcare Conference 2025 Transcript — Neutral
JNJ Seeking Alpha — November 11, 2025Johnson & Johnson ( JNJ ) UBS Global Healthcare Conference 2025 November 11, 2025 11:00 AM EST Company Participants Peter Menziuso Conference Call Participants Danielle Antalffy - UBS Investment Bank, Research Division Presentation Danielle Antalffy UBS Investment Bank, Research Division All right. Good morning, everyone.
LendingClub Corporation (LC) Analyst/Investor Day Transcript — Neutral
LC Seeking Alpha — November 11, 2025LendingClub Corporation ( LC ) Analyst/Investor Day November 5, 2025 9:00 AM EST Company Participants Artem Nalivayko - VP and Head of FP&A and Investor Relations Scott Sanborn - CEO & Director Kiran Aware Steven Mattics - Chief Lending Officer Mark Elliot - Chief Customer Officer Lukasz Strozek - Chief Technology Officer Andrew LaBenne - Chief Financial Officer Clarke Roberts John Morris Conference Call Participants Crispin Love - Piper Sandler & Co., Research Division Reginald Smith - JPMorgan Chase & Co, Research Division Giuliano Anderes-Bologna - Compass Point Research & Trading, LLC, Research Division David Scharf - Citizens JMP Securities, …
enGene Holdings Inc. (ENGN) Discusses Preliminary Data From LEGEND Pivotal Cohort in High-Risk BCG-Unresponsive NMIBC Transcript — Neutral
ENGN Seeking Alpha — November 11, 2025enGene Holdings Inc. ( ENGN ) Discusses Preliminary Data From LEGEND Pivotal Cohort in High-Risk BCG-Unresponsive NMIBC November 11, 2025 8:00 AM EST Company Participants Lauren Hopfer Ronald H. Cooper - President, CEO & Director Hussein Sweiti - Chief Medical Officer Conference Call Participants Suzanne Merrill Yanan Zhu - Wells Fargo Securities, LLC, Research Division Judah Frommer - Morgan Stanley, Research Division Sean McCutcheon - Raymond James & Associates, Inc., Research Division Mani Foroohar - Leerink Partners LLC, Research Division Paul Jeng - Guggenheim Securities, LLC, Research Division Leland Gershell - Oppenheimer & Co. Inc., Research Division Silvan Tuerkcan - …
KalVista Pharmaceuticals, Inc. (KALV) Q3 2025 Earnings Call Transcript — Neutral
KALV Seeking Alpha — November 11, 2025KalVista Pharmaceuticals, Inc. ( KALV ) Q3 2025 Earnings Call November 11, 2025 8:30 AM EST Company Participants Ryan Baker - Head of Investor Relations Benjamin Palleiko - CEO & Director Paul Audhya - Chief Medical Officer Nicole Sweeny - Chief Commercial Officer Brian Piekos - Chief Financial Officer Conference Call Participants Maurice Raycroft - Jefferies LLC, Research Division Stacy Ku - TD Cowen, Research Division Matthew Ryan Tan - Stifel, Nicolaus & Company, Incorporated, Research Division Joseph Schwartz - Leerink Partners LLC, Research Division Jonathan Wolleben - Citizens JMP Securities, LLC, Research Division Serge Belanger - Needham & Company, …
It's not often that a hypergrowth company complains about too much demand. But for Nebius Group NV (NASDAQ:NBIS), that's precisely the story.
Twin Disc's Q1 Loss Narrows Y/Y With Margin Gains and Sales Growth — Positive
TWIN Zacks Investment Research — November 11, 2025TWIN's Q1 FY26 results show narrower year-over-year loss per share and rising sales, margin expansion and defense demand strength, supported by the Kobelt acquisition and a robust backlog.
Can Opendoor's AI Turnaround Drive Profitability by 2026? — Positive
OPEN Zacks Investment Research — November 11, 2025OPEN's AI-driven pivot aims to cut costs and boost speed as it chases profitability by the end of 2026.
